DCF — TUFTS MEDICAL CENTER
Enterprise Value: $-724.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-724.8M
Enterprise Value
$-242.4M
PV of Cash Flows
$-482.4M
PV of Terminal Value
$-776.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $844.1M | $-38.0M | -4.0% | $-73.7M | $-67.0M |
| Year 2 | $869.4M | $-30.4M | -3.0% | $-67.2M | $-55.6M |
| Year 3 | $895.5M | $-22.4M | -2.0% | $-60.3M | $-45.3M |
| Year 4 | $922.4M | $-18.4M | -2.0% | $-57.5M | $-39.3M |
| Year 5 | $950.1M | $-16.6M | -2.0% | $-56.8M | $-35.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-724.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$819.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999981696912
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5